Vis enkel innførsel

dc.contributor.authorMullee, Amy
dc.contributor.authorRomaguera, Dora
dc.contributor.authorPearson-Stuttard, Jonathan
dc.contributor.authorViallon, Vivian
dc.contributor.authorStepien, Magdalena
dc.contributor.authorFreisling, Heinz
dc.contributor.authorFagherazzi, Guy
dc.contributor.authorMancini, Francesca Romana
dc.contributor.authorBoutron-Ruault, Marie-Christine
dc.contributor.authorKühn, Tilman
dc.contributor.authorKaaks, Rudolf
dc.contributor.authorBoeing, Heiner
dc.contributor.authorAleksandrova, Krasimira
dc.contributor.authorTjønneland, Anne
dc.contributor.authorHalkjær, Jytte
dc.contributor.authorOvervad, Kim
dc.contributor.authorWeiderpass, Elisabete
dc.contributor.authorSkeie, Guri
dc.contributor.authorParr, Christine Louise
dc.contributor.authorQuirós, José Ramón
dc.contributor.authorAgudo, Antonio
dc.contributor.authorSánchez, María-José
dc.contributor.authorAmiano, Pilar
dc.contributor.authorCirera, Lluis
dc.contributor.authorArdanaz, Eva
dc.contributor.authorKhaw, Kay-Tee
dc.contributor.authorTong, Tammy Y.N.
dc.contributor.authorSchmidt, Julie A.
dc.contributor.authorTrichopoulou, Antonia
dc.contributor.authorMartimianaki, Georgia
dc.contributor.authorKarakatsani, Anna
dc.contributor.authorPalli, Domenico
dc.contributor.authorAgnoli, Claudia
dc.contributor.authorTumino, Rosario
dc.contributor.authorSacerdote, Carlotta
dc.contributor.authorPanico, Salvatore
dc.contributor.authorBueno-de-Mesquita, Hendrik Bastiaan
dc.contributor.authorVerschuren, W.M. Monique
dc.contributor.authorBoer, Jolanda M.A.
dc.contributor.authorVermeulen, Roel
dc.contributor.authorRamne, Stina
dc.contributor.authorSonestedt, Emily
dc.contributor.authorVan Guelpen, Bethany
dc.contributor.authorHolgersson, Pernilla Lif
dc.contributor.authorTsilidis, Konstantinos K.
dc.contributor.authorHeath, Alicia K.
dc.contributor.authorMuller, David
dc.contributor.authorRiboli, Elio
dc.contributor.authorGunter, Marc J.
dc.contributor.authorMurphy, Neil
dc.date.accessioned2020-01-14T15:20:02Z
dc.date.accessioned2020-01-28T13:28:15Z
dc.date.available2020-01-14T15:20:02Z
dc.date.available2020-01-28T13:28:15Z
dc.date.issued2019-05-12
dc.identifier.citationMullee A, Romaguera D, Pearson-Stuttard, Viallon V, Stepien M, Freisling H, Fagherazzi G, Mancini FR, Boutron-Ruault M, Kühn T, Kaaks R, Boeing H, Aleksandrova K, Tjønneland A, Halkjær J, Overvad K, Weiderpass E, Skeie G, Parr CL, Quirós JR, Agudo A, Sánchez M, Amiano P, Cirera L, Ardanaz E, Khaw K, Tong TY, Schmidt JA, Trichopoulou A, Martimianaki G, Karakatsani A, Palli D, Agnoli C, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita HB, Verschuren WM, Boer JM, Vermeulen R, Ramne, Sonestedt E, Van Guelpen B, Holgersson, Tsilidis KK, Heath AK, Muller D, Riboli E, Gunter MJ, Murphy N. Association between soft drink consumption and mortality in 10 European countries. JAMA Internal Medicine. 2019:E1-E12en
dc.identifier.issn2168-6106
dc.identifier.issn2168-6106
dc.identifier.issn2168-6114
dc.identifier.urihttps://hdl.handle.net/10642/8018
dc.description.abstractImportance: Soft drinks are frequently consumed, but whether this consumption is associated with mortality risk is unknown and has been understudied in European populations to date. Objective: To examine the association between total, sugar-sweetened, and artificially sweetened soft drink consumption and subsequent total and cause-specific mortality. Design, Setting, and Participants: This population-based cohort study involved participants (n = 451 743 of the full cohort) in the European Prospective Investigation into Cancer and Nutrition (EPIC), an ongoing, large multinational cohort of people from 10 European countries (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom), with participants recruited between January 1, 1992, and December 31, 2000. Excluded participants were those who reported cancer, heart disease, stroke, or diabetes at baseline; those with implausible dietary intake data; and those with missing soft drink consumption or follow-up information. Data analyses were performed from February 1, 2018, to October 1, 2018. Exposure: Consumption of total, sugar-sweetened, and artificially sweetened soft drinks. Main Outcomes and Measures Total mortality and cause-specific mortality. Hazard ratios (HRs) and 95% CIs were estimated using multivariable Cox proportional hazards regression models adjusted for other mortality risk factors. Results: In total, 521 330 individuals were enrolled. Of this total, 451 743 (86.7%) were included in the study, with a mean (SD) age of 50.8 (9.8) years and with 321 081 women (71.1%). During a mean (range) follow-up of 16.4 (11.1 in Greece to 19.2 in France) years, 41 693 deaths occurred. Higher all-cause mortality was found among participants who consumed 2 or more glasses per day (vs consumers of <1 glass per month) of total soft drinks (hazard ratio [HR], 1.17; 95% CI, 1.11-1.22; P < .001), sugar-sweetened soft drinks (HR, 1.08; 95% CI, 1.01-1.16; P = .004), and artificially sweetened soft drinks (HR, 1.26; 95% CI, 1.16-1.35; P < .001). Positive associations were also observed between artificially sweetened soft drinks and deaths from circulatory diseases (≥2 glasses per day vs <1 glass per month; HR, 1.52; 95% CI, 1.30-1.78; P < .001) and between sugar-sweetened soft drinks and deaths from digestive diseases (≥1 glass per day vs <1 glass per month; HR, 1.59; 95% CI, 1.24-2.05; P < .001). Conclusions and Relevance: This study found that consumption of total, sugar-sweetened, and artificially sweetened soft drinks was positively associated with all-cause deaths in this large European cohort; the results are supportive of public health campaigns aimed at limiting the consumption of soft drinks.en
dc.description.sponsorshipEPIC (European Prospective Investigation into Cancer and Nutrition) was funded by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by the Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l’Education Nationale, and Institut National de la Santé et de la Recherche Médicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy); the Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF); ERC-2009-AdG 232997 and Nordforsk, and Nordic Centre of Excellence Programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS) (grant PI13/00061 to Granada, and grant PI13/01162 to EPIC-Murcia), Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology (Spain); Swedish Cancer Society, Swedish Research Council, and County Councils of Skåne and Västerbotten (Sweden); Cancer Research UK (grant 14136 to EPIC-Norfolk, and grants C570/A16491 and C8221/A19170 to EPIC-Oxford) and Medical Research Council (grant 1000143 to EPIC-Norfolk, and grant MR/M012190/1 to EPIC-Oxford) (United Kingdom). Dr Mullee’s work was supported by an IARC-Ireland Postdoctoral Research Training Fellowship from the Irish Cancer Society.en
dc.language.isoenen
dc.publisherAmerican Medical Association (AMA)en
dc.relation.ispartofseriesJAMA Internal Medicine;Volume 179, Number 11
dc.rightsThis is an open Access article Distributed under the terms of the CC-BY License. © 2019 Mullee A et al. JAMA Internal Medicine.en
dc.rights.urihttps://creativecommons.org/licenses/by/2.0/
dc.subjectSoft drink consumptionen
dc.subjectMortalitiesen
dc.subjectEuropeen
dc.subjectSugar sweeteningsen
dc.subjectArtificial sweeteningsen
dc.titleAssociation between soft drink consumption and mortality in 10 European countriesen
dc.typeJournal articleen
dc.typePeer revieweden
dc.date.updated2020-01-14T15:20:02Z
dc.description.versionpublishedVersionen
dc.identifier.doihttps://dx.doi.org/10.1001/jamainternmed.2019.2478
dc.identifier.cristin1739284
dc.source.journalJAMA Internal Medicine


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

This is an open Access article Distributed under the terms of the CC-BY License. © 2019 Mullee A et al. JAMA Internal Medicine.
Med mindre annet er angitt, så er denne innførselen lisensiert som This is an open Access article Distributed under the terms of the CC-BY License. © 2019 Mullee A et al. JAMA Internal Medicine.